Navigation Links
New Study Released Today Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
Date:6/5/2011

INDIANAPOLIS, June 5, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that PARAMOUNT, its Phase III study evaluating ALIMTA® (pemetrexed for injection) in the continuation maintenance setting, met its primary endpoint of progression-free survival, or the time a patient is alive without their disease worsening, for patients with a specific type of lung cancer called advanced nonsquamous non-small cell lung cancer (NSCLC).

"Continuation maintenance" treatment is when one of the same medicines used in first-line treatment setting is continued as maintenance therapy in an effort to control the cancer.  

Results from the study will be presented on Sunday, June 5 at 11:30 a.m. CDT during the Lung Cancer Oral Abstract Session (Abstract #CRA7510) at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill.  Lilly will present overall survival results from PARAMOUNT at a medical meeting in the future.

PARAMOUNT is the second study to evaluate the use of ALIMTA as a maintenance therapy in patients with advanced nonsquamous NSCLC, and the first study to evaluate the use of continuation maintenance with ALIMTA(1) following first-line ALIMTA plus cisplatin therapy.

Results of this multicenter, double-blind trial demonstrated the median progression-free survival measured from randomization (after first-line treatment) was 3.9 months on the ALIMTA arm as compared to 2.6 months on the placebo arm with a hazard ratio of 0.64.  Said another way, the study showed that ALIMTA continuation maintenance arm resulted in a 36 percent improvement of survival without disease worsening over the placebo arm. The maintenance disease control rate, or the percentage of patients achieving either a response or stable disease first measured at 6 weeks post-randomization was 71.8 percent (2.8%/69.0%) on the ALIMTA
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy
2. New Study Questions Ability of Radiology Benefit Managers to Lower Costs
3. A Recent Study by ITGs Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
4. Israeli Facility Study Demonstrates MGuard™ Stent System Helps Prevent Distal Embolization
5. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
6. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
7. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
8. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
9. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
10. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
11. U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
(Date:7/31/2015)... , July 31, 2015 Today, ... (NABP ® ) issued a report urging ... that action is taken against websites illegally selling ... Internet Drug Outlet Identification Program Progress Report for ... , thousands of websites illegally distribute medications ...
(Date:7/31/2015)... , July 31, 2015  Boston Children,s ... benefiting from 3D printing of their anatomy before ... life-threatening cerebrovascular malformations (abnormalities in the brain,s blood ... Reporting online today in the Journal of ... of 3D printing and synthetic resins to create ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4
... Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... study examining the immunogenicity and safety profiles of Fluzone High-Dose ... adults to a standard dose of Fluzone vaccine. The data ... Diseases Society of America on October 21, 2011. ...
... 21, 2011 Approximately 100 cherry tree saplings were ... newest park in the Morris County Park System, located ... Lane and celebrate the 100th anniversary of the ... to Washington D.C. in 1912.  More than 75 Daiichi ...
Cached Medicine Technology:Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 2Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 3Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 4Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 5Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 6Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 2Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 3Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 4
(Date:8/3/2015)... ... August 03, 2015 , ... Cambia ... for overall performance of the company’s Medicare and Federal Employee Programs (FEP) lines ... to deliver better health for members. In this role, Scott is responsible for ...
(Date:8/3/2015)... AZ (PRWEB) , ... August ... ... Inc. (EMSI), a leading provider of medical information, risk management and investigative ... company’s evolution and direction toward focused, expert information solutions that improve business ...
(Date:8/3/2015)... ... August 03, 2015 , ... Did you know that there ... looking for exceptional and affordable home care options which A-1 Home Care Agency specialize ... few of the credentials A-1 Home Care Agency is known for. ...
(Date:8/2/2015)... Provo, Utah (PRWEB) , ... August 03, 2015 ... ... and corporate training, will be attending and exhibiting at the Association for Healthcare ... August 7-8. , “We are pleased for the opportunity the AHDI conference ...
(Date:8/2/2015)... ... 2015 , ... For many “would be” entrepreneurs, starting a new business can prove to ... to start a business.” Neither needs be a major obstacle. , The U.S. has ... a business and be successful. The risks of starting a business can be high but ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 2Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 3Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 4Health News:Newport Board Group, an Advisory Firm Serving Middle Market Companies, Releases a 5 Step Guide to Starting a Successful Business for Under $1,000 5
... Hospital doctors warn that children playing football are at risk ... boots // . ,According to the British Medical ... have been attributed to tampon use. The condition is rare ... kidney damage can result with fatal results. ,The ...
... Uttar Pradesh has decided to take action against erring ... the number of patients //to be treated at the ... to stop the 'popular' practice of doctors, who arrive ... hour before their duty gets over. ,The ...
... Eastercroft nursing home in Caldercruix, Lanarkshire //. ... further cases of tuberculosis after the three elderly residents fell ... victims died in ‘early May’ the third succumbed to the ... to be recovering after being diagnosed with TB last October. ...
... Duke University Medical Center and Washington University in St. ... telephone-based counseling is a Godsend //. ,In ... Clinical Psychology, the researchers say that although the counseling ... in these patients, the quality of life did improve ...
... decided to extend its innovation beyond manufacturing computer chips. ... up with other medical and healthcare companies’ towards providing ... others have joined hands to enable high-end healthcare services ... led by Intel will seek to effectively merge electronics ...
... is grossly disappointed with the UN General Assembly declaration on ... earmarked prevention programs needed to battle the pandemic. // ... Society said 'The lack of clear targets I think in ... need in order to deliver prevention and treatment to the ...
Cached Medicine News:Health News:Budding Footballers at Risk from Blood Infection 2Health News:UP Government Fixes Work Schedules for Provincial Medical Service Doctors 2
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... IEC CL40 and FL40 Centrifuge Series ... and versatility to increase your productivity ... broad array of rotors and accessories ... microplate applications, the IEC CL40 and ...
... Glucose Monitoring System has the largest reading ... easy to see and hold. FreeStyle Freedom ... smallest sample of blood. And it's fastyou'll ... seconds. With 4 programmable alarms, you'll know ...
Platelet Aggregation Profiler...
Medicine Products: